|
On May 21, 2007, the U.S. Food and Drug Administration issued a safety alert on Avandia, the popular diabetes drug produced by GlaxoSmithKline. Data collected from clinical trials have shown there is potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia. Since the drug was approved in 1999, the FDA has been monitoring several heart-related adverse events, including fluid retention, edema and congestive heart failure. Recent data provided by the drug’s manufacturer suggested that patients receiving short-term treatment with Avandia may have a 30-40% greater risk of heart attack and other heart-related events than patients taking a placebo or other anti-diabetic therapy. This is particularly alarming because patients with diabetes are already at an increased risk of heart disease.
Injured Person Information:
Accident / Injury Information:
Case Description*
Please explain exactly what happened, trying to state
as thoroughly as possible who you believe was responsible
and why you believe that person was negligent:
|
Please explain the full extent of the victims injuries:
|
Comments / Additional Information
Is there anything else that would assist us in
understanding the facts of your case?
|
| 
